Correlation Between Mineralys Therapeutics, and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Mineralys Therapeutics, and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Hepion Pharmaceuticals.
Diversification Opportunities for Mineralys Therapeutics, and Hepion Pharmaceuticals
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mineralys and Hepion is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Hepion Pharmaceuticals
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Hepion Pharmaceuticals. In addition to that, Mineralys Therapeutics, is 1.7 times more volatile than Hepion Pharmaceuticals. It trades about -0.05 of its total potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.07 per unit of volatility. If you would invest 70.00 in Hepion Pharmaceuticals on August 26, 2024 and sell it today you would lose (4.00) from holding Hepion Pharmaceuticals or give up 5.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Hepion Pharmaceuticals
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Hepion Pharmaceuticals |
Mineralys Therapeutics, and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Hepion Pharmaceuticals
The main advantage of trading using opposite Mineralys Therapeutics, and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |